Advertisement

Reactions Weekly

, Volume 1710, Issue 1, pp 275–275 | Cite as

Ranibizumab

Parkinson's disease: case report
Case report
  • 9 Downloads

Reference

  1. Trifiro G, et al. Long-term intravitreal ranibizumab as a potential additional risk factor for neurodegeneration in Parkinson's Disease: A case report. Frontiers in Pharmacology 9: No. 608, 8 Jun 2018. Available from: URL: http://doi.org/10.3389/fphar.2018.00608 - Italy

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations